| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/31/1996 | EP0723442A1 Lactone compounds for treating patients with precancerous lesions |
| 07/31/1996 | EP0723441A1 Aminimide-containing molecules and materials as molecular recognition agents |
| 07/31/1996 | EP0723440A1 Therapeutic delivery compositions and methods of use thereof |
| 07/31/1996 | EP0723402A1 Senescent cell-derived inhibitors of dna synthesis |
| 07/31/1996 | EP0723398A1 Superoxide dismutase and mimetics thereof |
| 07/31/1996 | EP0557319B1 Therapeutic use of fibroblast growth factor |
| 07/31/1996 | EP0550665B1 Novel neurothrophic factor |
| 07/31/1996 | EP0511393B1 Hirudine mutant, production thereof, anticoagulant, secretory vector, microorganism transformed by said vector, and production of product from said microorganism |
| 07/31/1996 | EP0491849B1 A method for the purification of transforming growth factor (tgf-) |
| 07/31/1996 | EP0471754B1 Production of vascular endothelial cell growth factor and dna encoding same |
| 07/31/1996 | EP0469074B1 Cysteine added variants il-3 and chemical modifications thereof |
| 07/31/1996 | EP0446313B1 Fusion proteins comprising TraTp and at least one LHRH analogue |
| 07/31/1996 | EP0422175B1 Proteins which regulate the expression of vertebrate mhc class ii genes, dna sequences encoding them and pharmaceutical compositions |
| 07/31/1996 | EP0394326B1 Methods for the production of conformationally stabilized cell adhesion peptides |
| 07/31/1996 | CN1128047A Recombinant stratum corneum chymotryptic enzyme (SCCE) |
| 07/31/1996 | CN1128044A Fungicidal methods and compositions for killing yeast and sporular microorganisms |
| 07/31/1996 | CN1127992A Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant |
| 07/31/1996 | CN1127786A Recombinant human tumor necrosis factor derivative and preparing method thereof |
| 07/30/1996 | US5541334 Treating hiv |
| 07/30/1996 | US5541297 Hypoimmunogenic immunoconjugate of antibody fragment which binds to antigen associated with tumor or protozoa conjugated to drug or modified toxin and to polysaccharide or polyether through thiol-binding linker |
| 07/30/1996 | US5541296 Monocyte adhesion protein and monoclonal antibody thereto |
| 07/30/1996 | US5541294 Removal of antibodies from blood-derived compositions while retaining coagulation factors |
| 07/30/1996 | US5541293 Consensus human leukocyte interferon |
| 07/30/1996 | US5541292 Malaria vaccine |
| 07/30/1996 | US5541291 Polypeptides |
| 07/30/1996 | US5541290 Oligopeptide containing alpha-ketoamide group, treatment of alzheimer*s disease and other neurodegenerative disorders |
| 07/30/1996 | US5541288 Peptide having elastase inhibitory activity and producing method thereof |
| 07/30/1996 | US5541286 Bradykinin antagonist pseudopeptide derivatives of olefinic aminoalkanoic acids |
| 07/30/1996 | US5541206 Retroviral protease inhibiting compounds |
| 07/30/1996 | US5541162 Glutathione derivatives |
| 07/30/1996 | US5541161 Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin |
| 07/30/1996 | US5541160 Echinocandins |
| 07/30/1996 | US5541159 Calcitonin derivatives |
| 07/30/1996 | US5541158 Administering erythropoietin and iron |
| 07/30/1996 | US5541155 Acids and acid salts and their use in delivery systems |
| 07/30/1996 | US5541110 Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica |
| 07/30/1996 | US5541104 Monoclonal antibodies which bind to tumor rejection antigen precursor mage-1 |
| 07/30/1996 | US5541095 Dna encoding polypeptides for catalyzing deacetylation and sulfation of glycosamineglycan |
| 07/30/1996 | US5541088 Recombinant process of producing non-glycosylated B-cell defferentiation factor |
| 07/30/1996 | US5541085 Method for preparing orphan receptor ligands |
| 07/30/1996 | US5541077 Fungal stress proteins |
| 07/30/1996 | US5541073 Method of diagnosing epidermis differentiation disorders in a patient using a stratum corneum-specific antibody |
| 07/30/1996 | US5541071 Assay for identifying antagonists of gastrin and CCK-B receptors |
| 07/30/1996 | US5541068 Isolated and purified polypeptide encoded by messenger rna used to detect susceptibility of obesity |
| 07/30/1996 | US5540937 Process for preparing microspheres for the prolonged release of the LHRH hormone and its analogues, microspheres and formulations obtained |
| 07/30/1996 | US5540931 Antiinflammatory agents using lanolin, oil, polysorbates and cyclosporins |
| 07/30/1996 | US5540926 Gp39 protein |
| 07/30/1996 | US5540925 Anticarcinogenic, antitumor agents; bioactivity in vitro against human pancreatic and lung carcinoma cells |
| 07/30/1996 | US5540923 Antiviral, antitumor, from trophoblast cells |
| 07/30/1996 | US5540911 Methods of use of human manganese superoxide dismutase |
| 07/30/1996 | CA2072509C Cyclosporin emulsion compositions for oral administration |
| 07/30/1996 | CA1338501C Method of detecting antibody against htlv-iii |
| 07/25/1996 | WO1996022390A1 Methods, polypeptides, nucleotide sequence of xor-6, a vitamin d-like receptor from xenopus |
| 07/25/1996 | WO1996022384A1 Anti-cd 30 antibodies preventing proteolytic cleavage and release of membrane-bound cd 30 antigen |
| 07/25/1996 | WO1996022379A2 Direct gene transfer into the ruminant mammary gland |
| 07/25/1996 | WO1996022371A2 C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2 |
| 07/25/1996 | WO1996022370A1 Human fas gene promoter region |
| 07/25/1996 | WO1996022369A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 07/25/1996 | WO1996022368A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 07/25/1996 | WO1996022367A1 Nucleic acid encoding a stress-responsive subunit of human rna polymerase ii |
| 07/25/1996 | WO1996022360A1 Human prostatic specific reductase |
| 07/25/1996 | WO1996022310A1 Antibodies for use in cancer therapy and diagnosis |
| 07/25/1996 | WO1996022308A2 Appetite suppression factor and related methods |
| 07/25/1996 | WO1996022306A1 Novel peptide |
| 07/25/1996 | WO1996022305A2 Modified peptides |
| 07/25/1996 | WO1996022303A1 Therapeutic compound - fatty acid conjugates |
| 07/25/1996 | WO1996022112A1 Delivery of therapeutic agents by gene therapy |
| 07/25/1996 | WO1996022111A1 Local delivery and monitoring of drugs |
| 07/25/1996 | WO1996022108A1 The use of activated protein c for preparing a pharmaceutical preparation |
| 07/25/1996 | WO1996022107A1 Dried blood factor composition comprising trehalose |
| 07/25/1996 | WO1996022106A1 Cd8 antagonists |
| 07/25/1996 | WO1996022105A1 Pharmaceutical formulations comprising a salt of clavulanic acid, vancomycin and one or more beta-lactam antibiotics |
| 07/25/1996 | WO1996022104A1 Treatment of cerebral ischemia and cerebral damage with neuroprotective agent |
| 07/25/1996 | WO1996022103A1 Solid formulations for oral administration of cyclosporine a |
| 07/25/1996 | WO1996022101A1 Combined therapeutical treatment of hyperproliferative diseases |
| 07/25/1996 | WO1996022021A1 Protein hydroxylation inhibitors for fibroproliferative disorders |
| 07/25/1996 | WO1996022019A1 Diet compositions to treat ascites in domestic animals |
| 07/25/1996 | WO1996012021A3 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
| 07/25/1996 | CA2210897A1 Direct gene transfer into the ruminant mammary gland |
| 07/25/1996 | CA2210885A1 Protein hydroxylation inhibitors for fibroproliferative disorders |
| 07/25/1996 | CA2210718A1 Delivery of therapeutic agents by gene therapy |
| 07/25/1996 | CA2210679A1 Methods, polypeptides, nucleotide sequence of xor-6, a vitamin d-like receptor from xenopus |
| 07/25/1996 | CA2210618A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 07/25/1996 | CA2210500A1 Therapeutic compound - fatty acid conjugates |
| 07/25/1996 | CA2209931A1 The use of activated protein c for preparing a pharmaceutical preparation |
| 07/25/1996 | CA2207086A1 G protein-coupled receptor gene |
| 07/24/1996 | EP0723016A2 Activating factor of leukocytes |
| 07/24/1996 | EP0723015A1 Novel modified PF4 compositions and methods of use |
| 07/24/1996 | EP0723013A2 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 07/24/1996 | EP0722952A1 Hypoallergenic serocolostral fraction having high antibody activity, use and process for preparing such a fraction |
| 07/24/1996 | EP0722951A2 Method and apparatus for the production of TGF-beta and purified TGF-beta compositions |
| 07/24/1996 | EP0722738A2 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations |
| 07/24/1996 | EP0722737A1 Remedy for cranial nerve disorder |
| 07/24/1996 | EP0722736A1 Topical composition containing an antagonist of substance P |
| 07/24/1996 | EP0722724A1 Use of L-carnitine and its derivatives for reducing the toxic effects of cyclosporin-A and others immunosuppressants |
| 07/24/1996 | EP0722722A1 Use of an antagonist of substance P for the treatment of cutaneous erythema of neurogenic origin |
| 07/24/1996 | EP0722668A1 Improving the bulk density and drying economics of amino acids |
| 07/24/1996 | EP0722496A1 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 07/24/1996 | EP0722493A1 Modified dna virus vectors and uses therefor |
| 07/24/1996 | EP0722489A1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |